Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
The standard-of-care (SOC) MM therapy (RVD, ASCT, etc.) is designed to take MM patients with bone involvement or the usual symptoms of advanced newly diagnosed MM (NDMM) and stabilize them- return them to relatively normal health.
Frankly, figuring out how to normalize the health of stage 2 or 3 MM patients is a tremendous achievement. An achievement that will last as long as the NDMM patient’s PFS aka first remission lasts. Then MM survival get’s complicated…
Unfortunately, if you are not the average patient or if you have relapsed aka no longer in your first remission, standard-of-care MM therapies can be:
Let me be more specific.
If you have been diagnosed with pre-MM or early stage MM- a single plasmycytoma of bone, MGUS or SMM, undergoing SOC therapy will often reduce your quality of life (think short, long-term and late stage side effects) and speed you toward multi-drug resistance (MDR).
2. Cause organ damage (please see footnotes 9-13 below)
3. Become refractory– no longer kill your MM
All chemotherapy regimens eventually stop working. Oncology knows this.
What is the NDMM patient or relapsed MM survivor supposed to do? What is your solution? The solution to too much toxicity is to not undergo toxic therapies and to undergo therapies such as anti-angiogenic nutrition, supplementation and lifestyle therapies that have been shown to fight MM.
Curcumin is non-toxic.
The solution to the prospect of organ damage is to take one or more supplements that research has shown will protect organs.
Curcumin protects organs.
The solution to your MM becoming refractor or resistant to chemotherapy is to add evidence-based, integrative therapy to your chemotherapy regimens.
Curcumin integrates with thalidomide, revlimid, velcade, and more.
As a long-term MM survivor and MM cancer coach, I my experience is that:
Kills MM at all stages, both pre and full MM-
MGUS, SMM– “These findings suggest that curcumin might have the potential to slow the disease process in patients with MGUS and SMM…” (1), (2)
MM– “Long-term stabilisation of myeloma with curcumin” (3)
MM in high risk subtypes-“CU induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups” (4)
Curcumin Enhances Chemotherapy- Integrative Therapy-